Development and &lt;i&gt;in vivo&lt;/i&gt; evaluation of &lt;sup&gt;18&lt;/sup&gt;F-labeled PET tracers covalently targeting KRAS-G12C for noninvasive cancer diagnosis and therapy monitoring. The gene discussed is KRAS; the disease is cancer.